atomoxetine hydrochloride has been researched along with dextroamphetamine in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 20 (30.30) | 29.6817 |
| 2010's | 38 (57.58) | 24.3611 |
| 2020's | 8 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Biederman, J; Faraone, SV; Spencer, TJ; Wilens, TE | 1 |
| Bergman, J; Gasior, M; Kallman, MJ; Paronis, CA | 1 |
| Amler, RW; Brown, RT; Feldman, HM; Freeman, WS; Perrin, JM; Pierce, K; Stein, MT; Wolraich, ML | 1 |
| Pritchard, D | 2 |
| Asseburg, C; Drummond, M; Golder, S; Griffin, S; Hodges, Z; King, S; Richardson, G; Riemsma, R; Taylor, E; Weatherly, H | 1 |
| Asheim, H; Furu, K; Johansen, K; Nilsen, KB | 1 |
| Schlander, M | 2 |
| Manos, MJ | 1 |
| Harpin, VA | 1 |
| Allen, BD; Balci, F; Brunner, D; Fedolak, TE; Frank, KM; Gibson, JM; Kapustinski, BJ; Ludvig, EA | 1 |
| Asherson, P; Coghill, D; de Soysa, R; Hollis, C; McCarthy, S; Murray, M; Potts, L; Sayal, K; Taylor, E; Williams, T; Wong, IC | 1 |
| Hadijikoumi, I; Keen, D | 1 |
| Jensen, PS | 1 |
| Dopheide, JA | 1 |
| Cranswick, N; McCarthy, S; Potts, L; Taylor, E; Wong, IC | 1 |
| Asherson, P; Bilbow, A; Clifford, S; Coghill, D; DeSoysa, R; Hollis, C; McCarthy, S; Murray, M; Planner, C; Potts, L; Sayal, K; Taylor, E; Wong, IC | 1 |
| Hill, K; Kosten, T; Poling, J; Sofuoglu, M | 1 |
| Kratochvil, CJ; May, DE | 1 |
| Chakraborty, B; Manniche, PM; Meier, D; Schoedel, KA; Sellers, EM | 1 |
| Roman, MW | 1 |
| Katz, JL; Koffarnus, MN | 1 |
| Hanania, T; Paterson, NE; Ricciardi, J; Wetzler, C | 1 |
| Bizot, JC; David, S; Trovero, F | 1 |
| Chae, S; Patel, A; Steinberg-Epstein, R; Wigal, SB | 1 |
| Hodgkins, P; Meijer, WM; Sasané, R | 1 |
| Franke, AG; Huss, M; Konrad, A; Lieb, K | 1 |
| Cocker, PJ; Sun, H; Winstanley, CA; Zeeb, FD | 1 |
| Howland, RH | 1 |
| Bosch, R; Casas, M; Chalita, PJ; Palomar, G; Prats, L; Ramos-Quiroga, JA; Vidal, R | 1 |
| Asherson, P; Hodgkins, P; McCarthy, S; Murray, ML; Wilton, L; Wong, IC | 2 |
| Gluud, C; Simonsen, E; Storebø, OJ; Winkel, P | 1 |
| Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E | 1 |
| Lensing, MB; Opjordsmoen, S; Sandvik, L; Zeiner, P | 1 |
| Connor, DF; Faraone, SV; Jensen, PS; Miesle, LM; Rostain, A | 1 |
| Asherson, P; Hodgkins, P; McCarthy, S; Murray, M; Wilton, L; Wong, IC | 1 |
| Anderson, CS; Bloomfield, R; Caballero, B; Cardo, E; Civil, R; Coghill, D; Dittmann, RW; Higgins, N; Hodgkins, P; Lyne, A; Nagy, P | 1 |
| Dalsgaard, S; Nielsen, HS; Simonsen, M | 1 |
| Dickinson, TA; Fernando, AB; Mar, AC; Robbins, TW; Urcelay, GP | 1 |
| Hodgkins, P; Roskell, NS; Setyawan, J; Zimovetz, EA | 1 |
| Heyd, A; Nohr, FI; Norum, J; Olsen, AI; Totth, A | 1 |
| Adeyi, B; Anderson, CS; Caballero, B; Cardo, E; Civil, R; Coghill, DR; Dittmann, RW; Hodgkins, P; Nagy, P | 1 |
| Locatelli, I; Munda, B; Stuhec, M; Svab, V | 1 |
| Brown, EN; Kenny, JD; Solt, K; Taylor, NE | 1 |
| Dalsgaard, S; Leckman, JF; Mortensen, PB; Nielsen, HS; Simonsen, M | 1 |
| Dörfelt, A; Haen, E; Stegmann, B | 1 |
| Barkla, XM; McArdle, PA; Newbury-Birch, D | 1 |
| Bahmanyar, S; Furu, K; Karlstad, Ø; Kieler, H; Martikainen, JE; Pottegård, A; Zoëga, H | 1 |
| Gao, J; He, S; Li, Y; Wang, Q; Zhang, Y | 1 |
| Kapellen, TM; Kiess, W; Kostev, K; Reimann, R | 1 |
| Anderson, RH; Mattingly, GW | 1 |
| Osland, ST; Pringsheim, T; Steeves, TD | 1 |
| Anderson, KG; Ozga-Hess, JE | 1 |
| Coghill, D; Efron, D; Hearps, S; Hiscock, H; Mulraney, M; Sciberras, E | 1 |
| Shen, G; Shi, WX | 1 |
| Miller, J; Perera, B; Shankar, R | 1 |
| Grimmsmann, T; Himmel, W | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
| Avillach, P; Feroe, AG; Greenspun, P; Gutiérrez-Sacristán, A; Kohane, IS; Mousavi, S; Surati, R; Uppal, N | 1 |
| Brown, M; Higgins, GA; MacMillan, C; Silenieks, LB; Thevarkunnel, S | 1 |
| Coghill, D; Cortese, S; Newcorn, JH | 1 |
26 review(s) available for atomoxetine hydrochloride and dextroamphetamine
| Article | Year |
|---|---|
Novel treatments for attention-deficit/hyperactivity disorder in children.
Topics: Adolescent; Age Factors; Amphetamine; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Dextroamphetamine; Drug Administration Schedule; Humans; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Propylamines; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors | 2002 |
Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Caregivers; Central Nervous System Stimulants; Child; Combined Modality Therapy; Dextroamphetamine; Evidence-Based Medicine; Family; Female; Humans; Male; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Pemoline; Practice Guidelines as Topic; Propylamines; Randomized Controlled Trials as Topic; Stress, Psychological; Symporters | 2005 |
Attention deficit hyperactivity disorder in children.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate; Propylamines; Psychotherapy | 2005 |
A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Cost-Benefit Analysis; Dextroamphetamine; Humans; Methylphenidate; Models, Economic; Propylamines; Treatment Outcome | 2006 |
Attention deficit hyperactivity disorder in children.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate; Propylamines; Psychotherapy | 2006 |
Update on drugs for hyperactivity in childhood.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dextroamphetamine; Drug Costs; Humans; Methylphenidate; Propylamines; Treatment Outcome | 2007 |
Has NICE got it right? An international perspective considering the case of Technology Appraisal No. 98 by the National Institute for Health and Clinical Excellence (NICE).
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cost-Benefit Analysis; Dextroamphetamine; Germany; Humans; Internationality; Methylphenidate; Propylamines; Quality-Adjusted Life Years; Technology Assessment, Biomedical; United States | 2008 |
Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Dextroamphetamine; Humans; Lisdexamfetamine Dimesylate; Practice Patterns, Physicians'; Prodrugs; Propylamines; Treatment Outcome | 2008 |
Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Humans; Methylphenidate; Practice Guidelines as Topic; Propylamines | 2008 |
ADHD in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Humans; Methylphenidate | 2008 |
Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Uptake Inhibitors; Humans; Managed Care Programs; Methylphenidate; Propylamines | 2009 |
The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Humans; Managed Care Programs; Medication Adherence; Methylphenidate; Propylamines | 2009 |
Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines | 2010 |
[Stimulant and non-stimulant medication in current and future therapy for ADHD].
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Dextroamphetamine; Fatty Acids, Omega-3; Guanfacine; Histamine Agonists; Humans; Isoxazoles; Lisdexamfetamine Dimesylate; Memantine; Methylphenidate; Modafinil; Off-Label Use; Propylamines; Pyridines; Pyrrolidines; Receptors, AMPA | 2012 |
[Diagnosis and treatment of attention deficit hyperactivity disorder in adults].
Topics: Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Combined Modality Therapy; Comorbidity; Dextroamphetamine; Diagnostic Self Evaluation; Educational Status; Female; Humans; Interpersonal Relations; Interview, Psychological; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Neuropsychological Tests; Occupations; Propylamines; Quality of Life; Severity of Illness Index; Symptom Assessment | 2012 |
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Size; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Clonidine; Dextroamphetamine; Growth Disorders; Guanfacine; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Substance-Related Disorders; Suicide Prevention; Tic Disorders; Treatment Outcome | 2013 |
Toward quality care in ADHD: defining the goals of treatment.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Goals; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Quality of Health Care; Treatment Outcome | 2015 |
Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dopamine Uptake Inhibitors; Europe; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Models, Statistical; Propylamines; Treatment Outcome | 2014 |
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Comparative Effectiveness Research; Dextroamphetamine; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Patient Acceptance of Health Care; Propylamines; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Alcohol Drinking; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Drug Interactions; Humans; Illicit Drugs; Lisdexamfetamine Dimesylate; Methylphenidate; Substance-Related Disorders | 2015 |
An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Treatment Outcome | 2017 |
Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Clonidine; Comorbidity; Delayed-Action Preparations; Depressive Disorder; Dextroamphetamine; Guanfacine; Humans; Methylphenidate | 2016 |
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Desipramine; Dextroamphetamine; Female; Guanfacine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Selegiline; Tic Disorders | 2018 |
Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Cognition; Dextroamphetamine; Humans; Intellectual Disability; Methylphenidate; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD).
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Dextroamphetamine; Drug Resistance; Empirical Research; Humans; Methylphenidate; Randomized Controlled Trials as Topic | 2021 |
5 trial(s) available for atomoxetine hydrochloride and dextroamphetamine
| Article | Year |
|---|---|
Atomoxetine attenuates dextroamphetamine effects in humans.
Topics: Adrenergic Uptake Inhibitors; Adult; Affect; Atomoxetine Hydrochloride; Blood Pressure; Central Nervous System Stimulants; Dextroamphetamine; Drug Interactions; Female; Heart Rate; Humans; Hydrocortisone; Male; Norepinephrine Plasma Membrane Transport Proteins; Propylamines | 2009 |
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Atomoxetine Hydrochloride; Attention; Biogenic Monoamines; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Hemodynamics; Humans; Male; Middle Aged; Propylamines; Psychomotor Performance; Socioeconomic Factors; Substance-Related Disorders; Treatment Outcome; Young Adult | 2010 |
Social-skills and parental training plus standard treatment versus standard treatment for children with ADHD--the randomised SOSTRA trial.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methylphenidate; Parents; Propylamines; Social Behavior | 2012 |
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Male; Propylamines; Treatment Outcome | 2013 |
Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Double-Blind Method; Drug Administration Schedule; Humans; Lisdexamfetamine Dimesylate; Propylamines; Remission Induction; Severity of Illness Index; Treatment Outcome | 2014 |
35 other study(ies) available for atomoxetine hydrochloride and dextroamphetamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Cocaine; Desipramine; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Female; Infusion Pumps; Macaca mulatta; Methylphenidate; Propylamines; Reinforcement, Psychology; Self Administration; Substance-Related Disorders | 2005 |
[Prescribing of stimulants for ADHD in Nordland County].
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Prescriptions; Drug Utilization; Female; Humans; Male; Methylphenidate; Norway; Propylamines | 2007 |
Is NICE infallible? A qualitative study of its assessment of treatments for attention-deficit/hyperactivity disorder (ADHD).
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cost-Benefit Analysis; Dextroamphetamine; Evidence-Based Medicine; Humans; Methylphenidate; Models, Economic; Outcome and Process Assessment, Health Care; Propylamines; Qualitative Research; Technology Assessment, Biomedical; United Kingdom | 2008 |
Pharmacological manipulations of interval timing using the peak procedure in male C3H mice.
Topics: Animals; Atomoxetine Hydrochloride; Behavior, Animal; Chlordiazepoxide; Cognition; Cognition Disorders; Conditioning, Operant; Dextroamphetamine; Dopamine Agonists; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Mice, Inbred C3H; Nootropic Agents; Physostigmine; Propylamines; Psychophysiology; Reaction Time; Scopolamine; Sodium Chloride; Statistics as Topic; Time Factors; Time Perception | 2008 |
Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cohort Studies; Cross-Sectional Studies; Dextroamphetamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methylphenidate; Practice Patterns, Physicians'; Prevalence; Propylamines; United Kingdom; Withholding Treatment; Young Adult | 2009 |
Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cause of Death; Central Nervous System Stimulants; Child; Child, Preschool; Cohort Studies; Databases, Factual; Death, Sudden; Dextroamphetamine; Female; Humans; Male; Methylphenidate; Propylamines; Retrospective Studies; Risk Factors; Suicide; United Kingdom; Young Adult | 2009 |
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Attitude to Health; Central Nervous System Stimulants; Continuity of Patient Care; Cross-Sectional Studies; Dextroamphetamine; Drug Utilization Review; Family Practice; Female; Humans; Male; Medication Adherence; Methylphenidate; Outcome and Process Assessment, Health Care; Pharmacoepidemiology; Practice Patterns, Physicians'; Propylamines; Quality of Life; Survival Analysis; United Kingdom; Withholding Treatment; Young Adult | 2009 |
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Half-Life; Health Care Costs; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Pediatrics; Prodrugs; Propylamines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Newly approved once-daily formulations of medications for the treatment of Attention Deficit (Hyperactivity) Disorder (ADHD) in children and adolescents.
Topics: Administration, Cutaneous; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dextroamphetamine; Drug Administration Schedule; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Locus Coeruleus; Methylphenidate; Neurons; Nutrition Surveys; Prefrontal Cortex; Propylamines | 2010 |
Response requirement and increases in accuracy produced by stimulant drugs in a 5-choice serial reaction-time task in rats.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Choice Behavior; Dextroamphetamine; Male; Methylphenidate; Nicotine; Nicotinic Agonists; Propylamines; Rats; Rats, Sprague-Dawley; Reaction Time; Reinforcement Schedule; Signal Detection, Psychological | 2011 |
Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Benzophenones; Catechol O-Methyltransferase Inhibitors; Central Nervous System Stimulants; Choice Behavior; Dextroamphetamine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Nitrophenols; Norepinephrine; Prefrontal Cortex; Propylamines; Rats; Rats, Long-Evans; Reaction Time; Tolcapone | 2011 |
Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Stimulants; Desipramine; Dextroamphetamine; Impulsive Behavior; Male; Methylphenidate; Propylamines; Rats; Rats, Wistar | 2011 |
Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Drug Therapy, Combination; Drug Utilization; Humans; Incidence; Medical Records; Methylphenidate; Netherlands; Patient Compliance; Prevalence; Propylamines; Retrospective Studies | 2011 |
Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex.
Topics: Adrenergic Uptake Inhibitors; Amygdala; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Biomarkers; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase 5; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Extracellular Signal-Regulated MAP Kinases; Genetic Association Studies; Impulsive Behavior; Male; Neuronal Plasticity; Nucleus Accumbens; Propylamines; Rats; Rats, Long-Evans | 2012 |
The use of dopaminergic and stimulant drugs for the treatment of depression.
Topics: Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Depressive Disorder, Major; Dextroamphetamine; Dopamine; Dopamine Agents; Drug Therapy, Combination; Epinephrine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Norepinephrine; Propylamines | 2012 |
[Update on Current Care guidelines: ADHD (attention-deficit/hyperactivity disorder, children and adolescents)].
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delivery of Health Care, Integrated; Dextroamphetamine; Humans; Methylphenidate; Practice Guidelines as Topic; Propylamines | 2012 |
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Cohort Studies; Dextroamphetamine; Female; Humans; Incidence; Male; Methylphenidate; Middle Aged; Prevalence; Primary Health Care; Propylamines; Retrospective Studies; United Kingdom; Young Adult | 2012 |
Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence.
Topics: Adolescent; Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Female; Humans; Kaplan-Meier Estimate; Male; Methylphenidate; Patient Compliance; Propylamines; United Kingdom | 2012 |
Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey.
Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Delayed-Action Preparations; Dextroamphetamine; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Methylphenidate; Norway; Prognosis; Propylamines; Surveys and Questionnaires; Treatment Outcome | 2013 |
Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners.
Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Data Collection; Dextroamphetamine; General Practitioners; Humans; Male; Medication Adherence; Methylphenidate; Practice Patterns, Physicians'; Primary Health Care; Propylamines; Surveys and Questionnaires; Treatment Outcome; United Kingdom | 2013 |
Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish registe
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Denmark; Dextroamphetamine; Female; Humans; Male; Mental Disorders; Methylphenidate; Practice Patterns, Physicians'; Prevalence; Propylamines; Registries | 2013 |
The role of the nucleus accumbens shell in the mediation of the reinforcing properties of a safety signal in free-operant avoidance: dopamine-dependent inhibitory effects of d-amphetamine.
Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Auditory Perception; Avoidance Learning; Conditioning, Operant; Dextroamphetamine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Electroshock; Extinction, Psychological; Fear; Flupenthixol; GABA-A Receptor Agonists; GABA-B Receptor Agonists; Male; Nucleus Accumbens; Propylamines; Rats; Reinforcement, Psychology | 2014 |
Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study.
Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Utilization; Female; Humans; Male; Methylphenidate; Norway; Practice Patterns, Physicians'; Propylamines; Quality of Life; Registries; Residence Characteristics | 2014 |
Dextroamphetamine (but Not Atomoxetine) Induces Reanimation from General Anesthesia: Implications for the Roles of Dopamine and Norepinephrine in Active Emergence.
Topics: Anesthesia, General; Animals; Arousal; Atomoxetine Hydrochloride; Benzazepines; Consciousness; Dextroamphetamine; Dopamine; Electroencephalography; Male; Methyl Ethers; Methylphenidate; Norepinephrine; Propofol; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Sevoflurane | 2015 |
Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study.
Topics: Accidents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Cohort Studies; Denmark; Dextroamphetamine; Female; Humans; Male; Methylphenidate; Prospective Studies; Wounds and Injuries | 2015 |
Quantification of Methylphenidate, Dexamphetamine, and Atomoxetine in Human Serum and Oral Fluid by HPLC With Fluorescence Detection.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Child; Chromatography, High Pressure Liquid; Dextroamphetamine; Drug Monitoring; Female; Humans; Liquid-Liquid Extraction; Male; Methylphenidate; Middle Aged; Spectrometry, Fluorescence; Young Adult | 2016 |
Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Databases, Factual; Dextroamphetamine; Drug Utilization; Female; Humans; Male; Methylphenidate; Middle Aged; Psychotropic Drugs; Scandinavian and Nordic Countries; Young Adult | 2016 |
Prevalence of medically treated children with ADHD and type 1 diabetes in Germany - Analysis of two representative databases.
Topics: Adolescent; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cohort Studies; Comorbidity; Dextroamphetamine; Diabetes Mellitus, Type 1; Drug Prescriptions; Female; Germany; Humans; Hypoglycemic Agents; Insulin; Male; Methylphenidate; Neurotransmitter Uptake Inhibitors; Prevalence; Prospective Studies; Risk Factors; Sex Factors | 2016 |
Differential effects of d-amphetamine and atomoxetine on risk-based decision making of Lewis and Fischer 344 rats.
Topics: Animals; Atomoxetine Hydrochloride; Choice Behavior; Conditioning, Operant; Decision Making; Dextroamphetamine; Impulsive Behavior; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew; Reinforcement Schedule; Reinforcement, Psychology; Risk-Taking | 2019 |
Patterns of long-term ADHD medication use in Australian children.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Australia; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Prescriptions; Female; Humans; Longitudinal Studies; Male; Medication Adherence; Methylphenidate; Sex Distribution; Social Class | 2020 |
Amphetamine promotes cortical Up state: Role of adrenergic receptors.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Dextroamphetamine; Dopamine; Male; Methylphenidate; Neurons; Norepinephrine; Prazosin; Prefrontal Cortex; Rats; Receptors, Adrenergic | 2021 |
The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Prescriptions; Female; Germany; Guanfacine; Humans; Male; Methylphenidate; Practice Patterns, Physicians'; Young Adult | 2021 |
Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Bupropion; Child; Child, Preschool; Cohort Studies; Comorbidity; Data Mining; Depressive Disorder, Major; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Female; Health Services Accessibility; Humans; Insurance; Lisdexamfetamine Dimesylate; Male; Managed Care Programs; Prevalence; Retrospective Studies | 2021 |
Contrasting effects of d-amphetamine and atomoxetine on measures of impulsive action and choice.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Choice Behavior; Conditioning, Operant; Decision Making; Delay Discounting; Dextroamphetamine; Gambling; Impulsive Behavior; Male; Rats; Rats, Long-Evans; Reaction Time | 2021 |